Complete Evaluation of Adrenal Tumours in a Tertiary Care Institution in Thuringia, Germany

Abstract

Introduction and objective: Adrenal tumours, mainly incidentalomas, are an increasingly common clinical and diagnostic challenge. The aim of the present study was the retrospective evaluation of all patients with adrenal tumours treated in our university department from 1.1.1999–31.12.2013

Patients and methods: 187 patients (108 females: 79 males, mean age 57.7 years) were found to have adrenal tumours in our institution during the study period. All patients underwent basic and, when indicated, advanced analytical testing for hormonal activity. Tumours were classified according to patients’ gender, age at diagnosis, tumour localization and size, as well as benignity and malignancy when postinterventional histopathological examination was conducted.

Results: 134 (71.7%) patients had non-hormone secreting tumours, 17 (9.1%) pheochromocytoma, 13 (7.0%) Conn-syndrome, 13 (7.0%) adrenal Cushing’s disease, 1 congenital adrenal hyperplasia and 2 sexual hormone-secreting tumours. 7 (3.7%) tumours could not be definitively classified due to unclear or marginal test-results. Cushing’s disease was more prevalent in females (11 females: 2 males). 163 (87.2% of the total cohort) tumours were unilateral [95 (50.8%) left; 68 (36.4%) right] and 24 (12.8%) were bilateral. Tumour size was <3 cm in 109 (58.3%), 3–6 cm in 63 (33.7%) and >6 cm in 15 (8.0%) patients. 60 (32.1%) patients underwent adrenalectomy, thereof 88.9% of the patients with hormonally active tumours, while 8 (4.3%) were evaluated with ultrasound-guided biopsy. Malignancy was confirmed in 10 individuals (5.3%; 3 non-functioning tumours, 3 pheochromocytomas, 2 Cushing’s patients and 2 sexual-hormone secreting tumours), while 2 surgical specimens with histopathological diagnosis of pheochromocytoma showed signs of malignant changes. Benignity was histopathologically confirmed in 55 patients.

Conclusions: The prevalence of detected adrenal tumours is rising due to widely available and applied abdominal imaging procedures. The vast majority of them are benign, of small size (<3 cm) and hormonally inactive. Adrenalectomy is the therapeutic method of choice in big and/or confirmed hormone-secreting tumours.

• References

• 1 Zeiger MA, Siegelman SS, Hamrahian AH. Medical and surgical evaluation and treatment of adrenal incidentalomas. J Clin Endocrinol Metab 2011; 96: 2004-2015
• 2 Terzolo M, Stigliano A, Chiodini I et al. Italian Association of Clinical Endocrinologists. AME position statement on adrenal incidentaloma. Eur J Endocrinol 2011; 164: 851-870
• 3 Nieman LK. Approach to the patient with an adrenal incidentaloma. J Clin Endocrinol Metab 2010; 95: 4106-4113
• 4 Singh PK, Buch HN. Adrenal incidentaloma: evaluation and management. J Clin Pathol 2008; 61: 1168-1173
• 5 Grozinsky-Glasberg S, Szalat A, Benbassat CA et al. Clinically silent chromaffin-cell tumors: Tumor characteristics and long-term prognosis in patients with incidentally discovered pheochromocytomas. J Endocrinol Invest 2010; 33: 739-744
• 6 Karagiannis A, Mikhailidis DP, Athyros VG et al. Pheochromocytoma: an update on genetics and management. Endocr Relat Cancer 2007; 14: 935-956
• 7 McDermott S, O’Connor OJ, Cronin CG et al. Radiological evaluation of adrenal incidentalomas: current methods and future prospects. Best Pract Res Clin Endocrinol Metab 2012; 26: 21-33
• 8 Kaltsas G, Chrisoulidou A, Piaditis G et al. Current status and controversies in adrenal incidentalomas. Trends Endocrinol Metab 2012; 23: 602-609
• 9 Bülow B, Ahrén B. Swedish Research Council Study Group of Endocrine Abdominal Tumours . Adrenal incidentaloma-experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med 2002; 252: 239-246
• 10 Kasperlik-Zeluska AA, Rosłonowska E, Słowinska-Srzednicka J et al. Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol (Oxf) 1997; 46: 29-37
• 11 Barzon L, Fallo F, Sonino N et al. Development of overt Cushing’s syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 2002; 146: 61-66
• 12 Cho YY, Suh S, Joung JY et al. Clinical characteristics and follow-up of Korean patients with adrenal incidentalomas. Korean J Intern Med 2013; 28: 557-564
• 13 Grumbach MM, Biller BM, Braunstein GD et al. Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 2003; 138: 424-429
• 14 Granger P, Genest J. Autopsy study of adrenal in unselected normotensive and hypertensive patients. Canadian Medical Association Journal 1970; 103: 34-36
• 15 Barzon L, Sonino N, Fallo F et al. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 2003; 149: 273-285
• 16 Kloos RT, Gross MD, Francis IR et al. Incidentally discovered adrenal masses. Endocr Rev 1995; 16: 460-484
• 17 Mantero F, Terzolo M, Arnaldi G et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000; 85: 637-644
• 18 Hammarstedt L, Muth A, Wängberg B et al. Adrenal lesion frequency: a prospective, cross-sectional CT study in a defined region, including systematic re-evaluation. Acta Radiologica 2010; 51: 1149-1156
• 19 Morelli V, Palmieri S, Salcuni AS et al. Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics. Eur J Endocrinol 2013; 168: 235-241
• 20 Bondanelli M, Campo M, Trasforini G et al. Evaluation of hormonal function in a series of incidentally discovered adrenal masses. Metabolism 1997; 46: 107-113
• 21 Aso Y, Homma Y. A survey on incidental adrenal tumors in Japan. Journal of Urology 1992; 147: 1478-1481
• 22 Reincke M. Subclinical Cushing’s syndrome. Endocrinology and Metabolism Clinics of North America 2000; 29: 42-56
• 23 Comlekci A, Yener S, Ertilav S et al. Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. Endocrine 2010; 37: 40-46
• 24 Barzon L, Scaroni C, Sonino N et al. Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 1999; 84: 520-526
• 25 Kasperlik-Zaluska AA, Roslonowska E, Slowinska-Srzednicka J et al. 1.111 patients with adrenal incidentalomas observed at a single endocrinological center: incidence of chromaffin tumors. Ann N Y Acad Sci 2006; 1073: 38-46
• 26 Motta-Ramirez GA, Remer EM, Herts BR et al. Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. AJR Am J Roentgenol 2005; 185: 684-688
• 27 Mannelli M, Ianni L, Cilotti A et al. Pheochromocytoma in Italy: a multicentric retrospective study. European Journal of Endocrinology 1999; 141: 619-624
• 28 Amar L, Servais A, Gimenez-Roqueplo AP et al. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. Journal of Clinical Endocrinology and Metabolism 2005; 90: 2110-2116
• 29 Kopetschke R, Slisko M, Kilisli A et al. Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. Eur J Endocrinol 2009; 161: 355-361
• 30 Wachtel H, Cerullo I, Bartlett EK et al. Clinicopathologic Characteristics of Incidentally Identified Pheochromocytoma. Ann Surg Oncol 2014;
• 31 Bravo EL, Tagle R. Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev 2003; 24: 539-553
• 32 Griffin AC, Kelz R, Livolsi VA. Aldosterone-Secreting Adrenal Cortical Carcinoma. A Case Report and Review of the Literature. Endocr Pathol 2014;
• 33 Bernini GP, Moretti A, Argenio G et al. Primary aldosteronism in normokalemic patients with adrenal incidentalomas. European Journal of Endocrinology 2002; 146: 523-529
• 34 Mazza A, Zamboni S, Armigliato M et al. Endocrine arterial hypertension: diagnostic approach in clinical practice. Minerva Endocrinol 2008; 33: 127-146
• 35 Anagnostis P, Karagiannis A, Tziomalos K et al. Adrenal incidentaloma: a diagnostic challenge. Hormones (Athens) 2009; 8: 163-184 Review
• 36 Fassnacht M, Kroiss M, Allolio B. Update in adrenocortical carcinoma. J Clin Endocrinol Metab 2013; 98: 4551-4564
• 37 Ng L, Libertino JM. Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 2003; 169: 5-11
• 38 Mansmann G, Lau J, Balk E et al. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004; 25: 309-340
• 39 Zografos GN, Markou A, Ageli C et al. Laparoscopic surgery for adrenal tumors. A retrospective analysis. Hormones (Athens) 2006; 5: 52-56
• 40 Prinz RA. A comparison of laparoscopic and open adrenalectomies. Arch Surg 1995; 130: 489-492